The ANS Brain Tumor Center

The ANS Brain Tumor Center … An Integrated Approach to Care


Atlantic NeuroSurgical Specialists
310 Madison Ave.
Suite 300
Morristown, NJ 07960
(973) 285-7800


The Brain Tumor Center at Atlantic NeuroSurgical Specialists (ANS) is co-directed by Dr. Yaron A. Moshel and Dr. Brian Beyerl. Dr. Moshel serves as co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center and the Endoscopic Skull Base Surgery Center at Morristown Medical Center. Dr. Beyerl co-directs Overlook Medical Center’s CyberKnife Stereotactic Radiosurgery Center. ANS’s Brain Tumor Center provides comprehensive care to patients throughout the Tri-State area.


Why did ANS create a dedicated Brain Tumor Center?

Malignant brain tumors are relatively rare compared to other cancers. This sets up two challenges for patients:

(1) Finding a neurosurgeon who specializes in a broad spectrum of brain tumors and is an expert in the latest technologies and treatments.

(2) Managing the gamut of care required from multiple doctors – a neurosurgeon, oncologist, radiologist and other specialists – a fragmented approach that can compromise care and add stress to an already stressful situation.

Recognizing the impact these challenges can have on a patient’s recovery, ANS, the largest subspecialized neurosurgery practice in New Jersey, organized an integrated care system that brings together all brain tumor subspecialties in one place. This care model – offering extensive resources that rival those of major academic medical centers – makes it easier for patients to receive the best care with the best outcomes.

ANS’ comprehensive care approach enables ANS surgeons who specialize exclusively in the treatment of brain tumors to team with experts in neurosurgery, otolaryngology, radiation oncology, medical oncology, neuro-oncology, neuro-radiology, neuro-ophthalmology, neurology, neuropathology and physiatry. Consultations in nutrition and alternative medicine – as well as social services – bring the full spectrum of care to patients.


Are there benefits to this collaborative approach?

Just as no two patients are the same, no two brain tumors are the same. Each of ANS’s specialists and colleagues sees hundreds of patients each year with newly diagnosed and recurrent tumors of the brain and spinal cord. This collaboration of subspecialized, fellowship-trained physicians who treat a wide variety of conditions of the brain – combined with a shared knowledge base – empowers the team to determine the most effective, multidisciplinary individualized approach for each patient.


What about treating tumors that were previously classified as inoperable?

Armed with cutting-edge techniques like functional brain mapping and awake surgery, ANS physicians are able to be more aggressive about removing tumors that were previously deemed inoperable because of their location.

ANS is equipped with new technologies such as CyberKnife®, a non-invasive option that uses a beam of radiation to pinpoint and destroy a tumor without harming surrounding tissue. This technique – similar to the way focusing sunrays through a magnifying glass burns a spot on a piece of paper – provides the ability to treat a broad variety of tumors including those thought to be too risky to operate on in the past.


Are there other advances being explored by the ANS Brain Tumor Center?

ANS is part of a national consortium of oncologists and neurosurgeons across the country that shares the latest knowledge on particular tumors. ANS is also nationally known for pioneering clinical studies and clinical trials for new drugs and therapies. Currently, ANS is offering patients a new brain tumor vaccine and participating in a trial that involves the injection of a retrovirus to infect tumor cells. In addition, several new trials are pending approval. These options are not commonly available outside of a comprehensive center like the ANS Brain Tumor Center.

Be the first to review this item!

Bookmark this

17 Aug 2017